Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study
机构:[1]Jiangsu Provincial Key Laboratory of Critical Care Medicine, Departmentof Critical Care Medicine, Zhongda Hospital, School of Medicine, SoutheastUniversity, Nanjing 210009, Jiangsu, China[2]Department of Critical CareMedicine, Wuhan Jin-Yintan Hospital, Wuhan 430071, China[3]Departmentof Critical Care Medicine, Tongji Hospital, Tongji Medical College HuazhongUniversity of Science and Technology, Wuhan 430030, China华中科技大学同济医学院附属同济医院[4]Departmentof Critical Care Medicine, Union Hospital, Tongji Medical College HuazhongUniversity of Science and Technology, Wuhan 430022, China华中科技大学同济医学院附属协和医院[5]Departmentof Infection Disease, Wuhan Pulmonary Hospital, Wuhan, China[6]Departmentof Critical Care Medicine, Shenzhen Third Hospital, Shenzhen, China[7]Department of Critical Care Medicine, Huangshi Hospital of ChineseMedicine, Huangshi 435000, China[8]Department of Critical Care Medicine,Huangshi Central Hospital, Huangshi 435000, China[9]Department of Respiratoryand Critical Care Medicine, Beijing Institute of Respiratory Medicine,Beijing Chao‑Yang Hospital, Capital Medical University, Beijing 100020, China北京朝阳医院[10]Department of Critical Care Medicine, Xuanwu Hospital, Capital MedicalUniversity, Beijing 100053, China首都医科大学宣武医院[11]Emergency Department, The 900th Hospitalof Joint Service Corps of Chinese PLA, Fuzhou 350025, China[12]Departmentof Critical Care Medicine, Zhongshan Hospital, Fudan University,Shanghai 200032, China[13]Department of Critical Care Medicine, GuangzhouInstitute of Respiratory Health, The First Affiliated Hospital of GuangzhouMedical University, Guangzhou 510120, China[14]Department of Critical CareMedicine, The First Affiliated Hospital, College of Medicine, Zhejiang University,Hangzhou 310003, China浙江大学医学院附属第一医院[15]Department of Critical Care Medicine, NorthernJiangsu People’s Hospital, Clinical Medical School, Yangzhou University, Yangzhou225001, China江苏省人民医院[16]Medical ICU, Peking Union Medical College Hospital,Peking Union Medical College and, Chinese Academy of Medical Sciences,Beijing 100730, China
Purpose An ongoing outbreak of coronavirus disease 2019 (COVID-19) emerged in Wuhan since December 2019 and spread globally. However, information about critically ill patients with COVID-19 is still limited. We aimed to describe the clinical characteristics and outcomes of critically ill patients with COVID-19 and figure out the risk factors of mortality. Methods We extracted data retrospectively regarding 733 critically ill adult patients with laboratory-confirmed COVID-19 from 19 hospitals in China through January 1 to February 29, 2020. Demographic data, symptoms, laboratory values, comorbidities, treatments, and clinical outcomes were collected. The primary outcome was 28-day mortality. Data were compared between survivors and non-survivors. Results Of the 733 patients included in the study, the median (IQR) age was 65 (56-73) years and 256 (34.9%) were female. Among these patients, the median (IQR) APACHE II score was 10 (7 to 14) and 28-day mortality was 53.8%. Respiratory failure was the most common organ failure (597 [81.5%]), followed by shock (20%), thrombocytopenia (18.8%), central nervous system (8.6%) and renal dysfunction (8%). Multivariate Cox regression analysis showed that older age, malignancies, high APACHE II score, highd-dimer level, low PaO2/FiO(2)level, high creatinine level, high hscTnI level and low albumin level were independent risk factors of 28-day mortality in critically ill patients with COVID-19. Conclusion In this case series of critically ill patients with COVID-19 who were admitted into the ICU, more than half patients died at day 28. The higher percentage of organ failure in these patients indicated a significant demand for critical care resources.
基金:
Key Research and Development Plan of Jiangsu Province [BE2018743, BE2019749]; Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS) from China Academy of Medical Sciences and Peking Union Medical College (CN) [2020-I2M-2-005, 2019-I2M-1-001]
第一作者机构:[1]Jiangsu Provincial Key Laboratory of Critical Care Medicine, Departmentof Critical Care Medicine, Zhongda Hospital, School of Medicine, SoutheastUniversity, Nanjing 210009, Jiangsu, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Xie Jianfeng,Wu Wenjuan,Li Shusheng,et al.Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study[J].INTENSIVE CARE MEDICINE.2020,46(10):1863-1872.doi:10.1007/s00134-020-06211-2.
APA:
Xie, Jianfeng,Wu, Wenjuan,Li, Shusheng,Hu, Yu,Hu, Ming...&Du, Bin.(2020).Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study.INTENSIVE CARE MEDICINE,46,(10)
MLA:
Xie, Jianfeng,et al."Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study".INTENSIVE CARE MEDICINE 46..10(2020):1863-1872